Anti-EphB2 antibodies and methods using same

Details for Australian Patent Application No. 2006210837 (hide)

Owner Genentech, Inc.

Inventors Polakis, Paul; Mao, Weiguang

Agent Griffith Hack

Pub. Number AU-B-2006210837

PCT Pub. Number WO2006/083936

Priority 60/756,844 05.01.06 US; 60/648,541 31.01.05 US

Filing date 31 January 2006

Wipo publication date 10 August 2006

Acceptance publication date 12 July 2012

International Classifications

C07K 16/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61K 47/48 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 35/00 Antineoplastic agents

C07K 16/30 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 1/21 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/13 Mutation or genetic engineering - Immunoglobulins

C12N 15/85 Mutation or genetic engineering - for animal cells

G01N 33/574 Investigating or analysing materials by specific methods not covered by groups - for cancer

G01N 33/577 Investigating or analysing materials by specific methods not covered by groups - involving monoclonal antibodies

Event Publications

26 July 2007 PCT application entered the National Phase

  PCT publication WO2006/083936 Priority application(s): WO2006/083936

12 July 2012 Application Accepted

  Published as AU-B-2006210837

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006210838-Agents and methods related to reducing resistance to apoptosis-inducing death receptor agonists

2006210834-Infusion delivery system